Actively Recruiting

Age: 18Years +
All Genders
ID07255105

The First Phase of the Closed-loop Improvement Project for Preventing CLABSI

Led by Jianfeng Xie · Updated on 2025-11-28

1846

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying central venous catheter-related bloodstream infections (CLABSI) in intensive care units (ICUs) across China. CLABSI is a common and serious infection linked to central venous catheters used in critical care, causing extended hospital stays and increased costs. The study aims to understand the current rates of CLABSI and the factors influencing these infections, especially following changes in the healthcare environment during the COVID-19 pandemic, to help improve prevention strategies nationwide. This observational study focuses on adult ICU patients who have central venous catheters expected to remain in place for more than 48 hours. Patients are closely monitored for the occurrence of CLABSI, and data are collected prospectively across multiple ICUs in China. The study will run for an average of six months to observe and record infection rates and related factors. Participants will be admitted to the ICU with a central venous catheter and followed to track infection incidence. Researchers will collect relevant clinical information and monitor the patients throughout their ICU stay. The main outcome measured is the rate of CLABSI during the study period. This information will help guide future efforts to reduce catheter-related infections in critical care settings.

CONDITIONS

Brief Title

Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Admitted to the ICU with a central venous catheter expected to remain in place for more than 48 hours (including newly placed or continued qualified catheters)
  • Patients aged 18 years or older
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Patients with a central venous catheter indwelled for more than 24 hours before ICU admission who will not have it replaced immediately
  • Patients re-admitted to the ICU during the study period
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 6 months

Participants who have a central venous catheter in the ICU are observed for bloodstream infections.

Ongoing observation during ICU stay

Trial Site Locations

Total: 1 location

1

Zhongda Hospital Affiliated to Southeast University

Nanjing, Jiangsu, China

Actively Recruiting

Loading map...

Research Team

C

cai chenglong

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Multicenter Clinical Translational Study of ICU-NO CRBSI Bas...

CRBSI - Catheter Related Bloodstream Infection

Actively Recruiting

1 location

Tunneled Versus Non-Tunneled Peripherally Inserted Central C...

CLABSI - Central Line Associated Bloodstream Infection

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here